The Chemours Company
CC
$12.79
$0.322.57%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -7.43% | 18.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.43% | 18.06% | |||
| Cost of Revenue | -5.76% | 18.11% | |||
| Gross Profit | -15.47% | 17.80% | |||
| SG&A Expenses | -41.01% | 47.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.85% | 20.55% | |||
| Operating Income | 44.44% | -18.18% | |||
| Income Before Tax | 119.54% | -- | |||
| Income Tax Expenses | -107.56% | 2,875.00% | |||
| Earnings from Continuing Operations | 115.79% | -9,400.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 115.75% | -9,425.00% | |||
| EBIT | 44.44% | -18.18% | |||
| EBITDA | 20.39% | -7.88% | |||
| EPS Basic | 115.74% | -9,398.13% | |||
| Normalized Basic EPS | 302.91% | -61.32% | |||
| EPS Diluted | 115.71% | -8,366.67% | |||
| Normalized Diluted EPS | 301.74% | -61.32% | |||
| Average Basic Shares Outstanding | 0.05% | 0.21% | |||
| Average Diluted Shares Outstanding | 0.36% | 0.21% | |||
| Dividend Per Share | 0.00% | -65.00% | |||
| Payout Ratio | 7.35% | 1.00% | |||